Ads
related to: cost of lovaza generic
Search results
Results From The WOW.Com Content Network
Ethyl eicosapentaenoic acid (E-EPA) was the second fish-oil drug to be approved, after omega-3-acid ethyl esters (GlaxoSmithKline's Lovaza, which was approved in 2004. [31] [7] [32]) Initial sales were not as robust as Amarin had hoped. The labels for the two drugs were similar, but doctors prescribed Lovaza for people who had triglycerides ...
Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 Company(ies) Disease/Medical Use ... Lovaza: Omega-3 fatty acid ethyl esters: 258,177: 2.90%: GlaxoSmithKline:
Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007 for $1.65B. [1] Co-founded by Joseph J. Krivulka. It was known for six major products, including Lovaza (Omega-3), Axid (H2 blocker), Dynacirc CR (calcium channel blocker), Antara (fenofibrate), InnoPran XL (beta blocker), Lescol XL (Fluvastatin), and Rythmol SR (Class IC anti-arrhythmic).
Billionaire entrepreneur, co-host of ABC's Shark Tank, and Dallas Mavericks co-owner Mark Cuban's latest venture is the Mark Cuban Cost Plus Drug Company. It aims to tackle the high cost and lack ...
The over 250 drug hikes represent an increase from Dec. 29 last year when drugmakers unveiled plans to raise prices on more than 140 brands of drugs. Drug companies are also reducing some prices ...
In 2009, generic companies Teva Pharmaceuticals and Par Pharmaceutical made clear their intentions to file Abbreviated New Drug Applications ("ANDAs") to bring generics to market, and in April 2009, Pronova sued them from infringing the key US patents covering Lovaza, US 5,656,667 (due to expire in April 2017), US 5,502,077 (exp March 2013 ...
Ad
related to: cost of lovaza generic